drug industry
The Latest
-
Takeda Pharmaceutical Commits To China Expansion
Takeda Pharmaceutical has spent more than 1.5 billion yuan over the past five years to build its business in China. 
Takeda Pharmaceutical has spent more than 1.5 billion yuan over the past five years to build its business in China. -
Asian Countries Consider Ditching AstraZeneca COVID Trial After Volunteer Gets Transverse Myelitis
Whether the illness was directly linked to AstraZeneca's vaccine is unclear, reports say. AstraZeneca declined to comment. 
Whether the illness was directly linked to AstraZeneca's vaccine is unclear, reports say. AstraZeneca declined to comment. -
Johnson & Johnson Cuts Prices For TB Drug Amid Pandemic
Johnson & Johnson is slashing the price for its tuberculosis drug bedaquiline to bolster its usage amid the global pandemic. 
Johnson & Johnson is slashing the price for its tuberculosis drug bedaquiline to bolster its usage amid the global pandemic. -
Merck Finally Joining Global Race To Develop Covid-19 Vaccine
Apart from acquiring Austrian vaccine maker Themis Bioscience, Merck is also working with a number of other medical firms to develop separate coronavirus vaccines. 
Apart from acquiring Austrian vaccine maker Themis Bioscience, Merck is also working with a number of other medical firms to develop separate coronavirus vaccines. -
Merck Expects $2.1 Billion Sales Hit From Coronavirus Pandemic
Merck expects a huge hit on its sales this year given that more than two-thirds of its products need to be administered by doctors. 
Merck expects a huge hit on its sales this year given that more than two-thirds of its products need to be administered by doctors. -
Chinese Biotech Firm Akesobio Successfully Launches $330 Million Hong Kong IPO
Akesobio's 15.95 million shares made available to Hong Kong investors were oversubscribed 639 times during its debut. 
Akesobio's 15.95 million shares made available to Hong Kong investors were oversubscribed 639 times during its debut. -
China's Innovent Biologics Joins Global Race To Develop Coronavirus Cure
Innovent Biologics is trying to identify antibodies that can be used as part of a long-term cure for the viral pandemic. 
Innovent Biologics is trying to identify antibodies that can be used as part of a long-term cure for the viral pandemic. -
InnoCare Pharma Raises $289 Million In Hong Kong IPO Amid Market Downturn
Shares of the Beijing-based cancer drug producer was 300 times oversubscribed amid strong interest from global investors. 
Shares of the Beijing-based cancer drug producer was 300 times oversubscribed amid strong interest from global investors. -
Gilead Sciences To Buy Cancer Treatment Firm Forty Seven In $4.9 Billion Deal
The acquisition will give Gilead access to Forty Seven's lead cancer drug called Magrolimab, which is supposedly able to turn off a tumor cell's CD47 signals. 
The acquisition will give Gilead access to Forty Seven's lead cancer drug called Magrolimab, which is supposedly able to turn off a tumor cell's CD47 signals. -
China's New Drug Reimbursement Policy Saving Lives And Improving Public Health
With the new drug reimbursement policy, the financial burden on patients using the drugs on the list is effectively reduced by an average of 80 percent. 
With the new drug reimbursement policy, the financial burden on patients using the drugs on the list is effectively reduced by an average of 80 percent.
